Promethean®, a leading global tech company and brand owned by Mynd.ai, Inc. (NYSE American: MYND) is bringing its award-winning interactive displays and software to InfoComm 2026, the largest...

Diebold Nixdorf (NYSE: DBD), a world leader in transforming the way people bank and shop, today announced Octavio Marquez, president and chief executive officer, and Tom Timko, executive vice...

Halia Therapeutics, Inc., The Genetic Resilience Company™, a clinical-stage biopharmaceutical company advancing first-in-class inflammation therapies anchored in protective human genetics, today...

The 10th Silk Road International Exposition and The Investment and Trade Forum for Cooperation between East & West China ("10th Silk Road Intl. Expo") was held successfully from May 21 to 25 in Xi'an.

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases,...

COMPUTEX 2026 to Showcase Cyber Risk Quantification, Cybersecurity Digital Twin, AI Governance DALLAS, May 28, 2026 /PRNewswire/ -- TrendAI™, the enterprise cybersecurity business from Trend...

Blood Cancer United announced today that new data across its portfolio of funded research will be presented in more than 50 abstracts at the 2026 American Society of Clinical Oncology (ASCO)...

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's senior management team will participate...

Evidence-based resource from Viver Health, supported by Gilead Sciences, Inc. and endorsed by AONN+ to improve understanding, communication, and care for Spanish-speaking individuals living with...

PeproMene Bio, Inc. announced today that updated clinical data from its ongoing Phase 1 study evaluating PMB-CT01, an investigational B-cell activating factor receptor (BAFF-R)-targeted CAR T-cell...